Effect of WT1 antisense mRNA on the induction of apoptosis in ovarian carcinoma SKOV3 cells

European Journal of Gynaecological Oncology

Volumn 32, Issue 6, 2011, Pages 651-656

  Huo, X ^a   Ren, L ^b   Shang, L ^a   Wang, X ^a   Wang, J ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Antisense oligonucleotide; Ovarian epithelial carcinoma; SKOV3 cells; Transfection; WT1 gene

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; ANTISENSE OLIGONUCLEOTIDE; COMPLEMENTARY RNA; LIPOFECTAMINE; WT1 PROTEIN;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE CHECKPOINT; CELL PROLIFERATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; OVARY CARCINOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; HUMANS; OVARIAN NEOPLASMS; RNA, ANTISENSE; RNA, MESSENGER; TRANSFECTION; WT1 PROTEINS;

EID: 84862936758     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Call K.M., Glaster T., Ito C.Y. et al.: "Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus". Cell, 1990, 60, 509.
2. Harber A., Bukler J., Glaser T. et al.: "An internal deletion within an 11p13 zinc finger gene contributes to the development of wilm's tumor". Cell, 1990, 6, 1257.
3. Boublikova L., Kalinova M., Ryan J., Quinn F. et al.: "Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoring". Leukemia, 2006, 20, 254.
4. Domfeh A.B., Carley A.L., Striebel J.M. et al.: "WT1 immunoreactivity in breast carcinoma: selective expression in pure and mixed mucinous subtypes". Mod. Pathol., 2008, 21, 1217.
5. Phelan S.A., Lindberg C., Call K.M. et al.: "Wilms' tumor gene WT1 mRNA is down regulated during induction of erythroid and megakaryocytic diferentiation of K562 cells". Cell. Growth Differ., 1994, 5, 677.
6. Wang Z.Y., Qiu Q.Q., Deuel T.F.: "The Wilms' tumor gene product WT1 activates or supresses transcription through separate functional domains". Biol. Chem., 1993, 268, 9172.
7. Hylander B., Repasky E., Shrikant P. et al.: "Expression of Wilms tumor gene (WT1) in epithelial ovarian cancer". Gynecol. Oncol., 2006, 101, 12.
8. Larsson S.H., Charlien J.P., Miyayawa K. et al.: "Subnuclear localization of WT1 in splicing localization of domains is regulated by alternative splicing". Cell, 1995, 81, 391.
9. Wang Z. Y., Qiu Q.Q., Deuel T.E.: "The Wilms' tumor gene product WT1 activates or supresses transcription through separate functional domains". Biol. Chem., 1993, 268, 9172.
10. Gao L., Bellantuono I., Elsässer A., Marley S.B., Gordon M.Y., Goldman J.M. Stauss H.J.: "Selective elimination of leukemac CD34 progenitor cells by cytotoxic T-lymphocytes specific for WT1". Blood, 2000, 95, 2198.
11. Morita S., Oka Y., Tsuboi A., Kawakami M., Maruno M., Izumoto S. et al.: "A phase I/II trial of a WT1 (Wilms' tumor gene) peptide vaccine in patients with solid malignancy: safety assessment based on the phase I data". Jpn. J. Clin. Oncol., 2006, 36, 231.